{'fraction_non_alphanumeric': 0.01556420233463035, 'fraction_numerical': 0.016861219195849545, 'mean_word_length': 5.655172413793103, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Diagnosis and treatment of malignant pancreatic endocrine tumour.

OBJECTIVE
To summarize our experience in the diagnosis and treatment of malignant pancreatic endocrine tumour.


METHODS
We retrospectively reviewed 36 cases of malignant pancreatic endocrine tumours in our hospital from July 1987 to April 2002, and summarized its clinical features.


RESULTS
Liver metastasis was the main malignant manifestation of malignant pancreatic endocrine tumours (incidence rate 72.2%). Removals of primary lesion and isolated hepatic metastatic lesion were means of curative therapy. Interventional chemotherapy was an important adjuvant treatment.


CONCLUSION
Comprehensive therapy plays an important role in improving the prognosis of malignant pancreatic endocrine tumour.